pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 6·1 min read
save

Amgen, AbbVie say IRA negotiations impacted Q1 sales

At least two drugmakers say they’re feeling the impact of the Inflation Reduction Act, after the first drug prices negotiated under the law took effect in January. Amgen and AbbVie reported in their first-quarter earnings ...

May 6, 2026·read at Endpoints ↗

May 6, 2026 03:05 PM EDTUpdated 03:51 PM PharmaMarketing Am­gen, Ab­b­Vie say IRA ne­go­ti­a­tions im­pact­ed Q1 sales Nicole DeFeudis Senior Reporter At least two drug­mak­ers say they’re feel­ing the im­pact of the In­fla­tion Re­duc­tion Act, af­ter the first drug prices ne­go­ti­at­ed un­der the law took ef­fect … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
81 words · retrieved May 6
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ABBVIE2AMGEN2

related stories

  • 17h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • 23h agoAbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trialFierce Biotech
  • 1d agoThe top 12 companies hiring in biopharma nowBioSpace
  • Aug 27Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerateBioSpace
  • Aug 25After some ‘tough years,’ Frontier’s CEO is ramping up ambitions for precision med platformFierce Biotech